Immunome Inc. (IMNM) — Institutional Holders, Q2 2026 (page 3)
204 institutional investment managers reported a IMNM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 204. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IMNM 13F holders ranked 201–204 of 204
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 201 | Stone House Investment Management#201 · 5 sh | 5 | $106.00 | — | New |
| 202 | Rockefeller Capital Management L.P.#202 · 4 sh | 4 | $85.00 | 0.00% | 0.0% |
| 203 | Clearstead Advisors#203 · 4 sh | 4 | $85.00 | 0.00% | New |
| 204 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#204 · 108,234 sh | 108,234 | — | — | -2.9% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.